Value and Access Head, Immunology & Neuroscience, LACan region

The Region Value & Access (V&A) Therapeutic Area Head oversees the regional execution of V&A strategies for the assigned Therapeutic Areas - Immunology and Neurology, ensuring alignment with international strategies and country needs. Through extended membership of Integrated Product Access Teams, Regional TA influences the development of V&A strategies for the markets within the LACan region (Latin America and Canada). The role drives access readiness, pricing and lifecycle inputs, and cross-country collaboration to secure timely, sustainable and value-based patient access. It builds V&A capabilities, ensures strong performance management, and supports high-quality Launch Readiness Review (LRR) preparation. This role also partners closely with regional and country teams such as Medical, Commercial, Public Affairs, and other functions, to address access barriers, shape the external environment, and enable coherent regional execution.
About the Role
#LI-Hybrid

This position will be located at the East Hanover, NJ site and will not have the ability to be located remotely. This position will require travel as defined by the business (domestic and/ or international).

Key Responsibilities:

Drive Regional V&A Strategy Execution: Lead the execution of Therapeutic Area (TA) value and access strategies across the region, ensuring strong alignment with international direction while adapting to diverse country healthcare system (HCS) needs.
Shape Access Strategy in Growth Markets: Actively influence V&A strategies for priority markets through participation in cross-functional governance (e.g., Integrated Product Access Teams), ensuring tailored and impactful access approaches.
Lead Launch Readiness (LRR) for V&A: Own the TA-specific V&A contribution to Launch Readiness Reviews, ensuring timely delivery, risk identification, and robust action planning in collaboration with Medical, Commercial, and Corporate Affairs.
Drive Access Performance & Execution Excellence: Monitor and optimize access performance across countries using advanced analytics (e.g., dashboards, Access360), identifying opportunities to improve payer engagement, coverage, and execution impact.
Provide Strategic Pricing Leadership: Contribute to regional pricing strategy and governance by delivering TA-specific insights, including pricing assumptions, gross-to-net optimization, and development of robust pricing business cases in partnership with Finance and key stakeholders.
Expand Private Sector & Innovative Funding Models: Develop and scale private sector partnerships and alternative funding solutions to enhance access to priority products and disease areas.
Shape External Environment & Policy Influence: Drive strategic engagement with external stakeholders, contributing to policy shaping, payer engagement, and advocacy efforts while addressing systemic access barriers and leading pre-launch HCS readiness activities.
Build Regional V&A Capabilities: Strengthen TA-specific capabilities (e.g., pricing, HEOR, HTA, negotiation, evidence generation) through tools, training, and best-practice sharing, fostering a strong community of practice across markets.
Enable Cross-Functional Leadership & Collaboration: Act as a key regional leader, collaborating closely with Medical, Commercial, Regulatory, Public Affairs, and country teams to ensure alignment, knowledge exchange, and successful execution of strategic objectives.
Develop Talent and Drive High-Performance Culture: Champion capability building, succession planning, and ethical leadership, embedding a culture of compliance, collaboration, and enterprise mindset across the V&A organization.